Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma

This study is currently recruiting participants.

Study NCT00636168 Information provided by Bristol-Myers Squibb

First Received: March 7, 2008 Last Updated: November 16, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	September 2014
Estimated Primary Completion Date:	October 2012 (Final data collection date for primary outcome measure)